1. Labeling for biosimilar products Publication: Silver Spring, MD : Center for Drug Evaluation and Research, July 2018 Subject(s): Biosimilar PharmaceuticalsDrug Labeling -- standardsHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Cost savings Author(s): Steiner, David J., author Publication: [Toronto, Ontario] : Thomson Reuters, 23-December-2019 Subject(s): Cost Control -- legislation & jurisprudenceCost SavingsDrug Costs -- legislation & jurisprudenceEconomics, PharmaceuticalLegislation, DrugAccess to InformationBiosimilar PharmaceuticalsCommerceConflict of InterestDrug IndustryInsurance, Pharmaceutical ServicesManaged Care ProgramsMedicaid -- economicsMedicare Part D -- economicsPatents as TopicState GovernmentHumansUnited States
